Clinical Trials Logo

Pelvic Floor Disorders clinical trials

View clinical trials related to Pelvic Floor Disorders.

Filter by:

NCT ID: NCT02875977 Completed - Clinical trials for Pelvic Floor Disorders

Does a Patient Education Video Augment Pelvic Floor Physical Therapy Compliance?

Start date: August 3, 2016
Phase: N/A
Study type: Interventional

The investigators intend to measure compliance with attending pelvic floor physical therapy (PFPT) in a Urogynecology population by randomizing patients to either viewing a four minute educational video or reading a handout explaining the therapy.

NCT ID: NCT02860897 Withdrawn - Surgery Clinical Trials

Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery

Start date: July 2016
Phase: Phase 4
Study type: Interventional

PURPOSE: To evaluate patient adherence to cream versus tablet based local estrogen therapy by randomizing treatment modalities to determine differences in adherence to either form. HYPOTHESIS: There is no difference in adherence to cream versus tablet based local estrogen therapy when prescribed as a 6 week course of postoperative therapy after female pelvic reconstructive surgery.

NCT ID: NCT02774798 Completed - Clinical trials for Pelvic Floor Disorders

Correlation of Anal Acoustic Reflectometry Parameters With Degree of Rectal Intussusception and Prolapse

Start date: April 2016
Phase:
Study type: Observational

Anal Acoustic Reflectometry (AAR) is a reliable and reproducible technique that has been studied in our department over the last 6 years. Sound waves pass into a balloon placed in the anal canal and are used to measure the cross-sectional area. By gradually increasing and decreasing the pressure in the balloon the investigators can measure the pressure at which the cross-sectional area starts to increase and decrease, and the anal canal starts to open and close. This assessment mimics the natural opening and closing of the anal canal and the effect of squeezing the muscles. Rectal intussusception occurs when the rectal wall telescopes into itself distally and is termed prolapse when it protrudes through the anal canal. Not all patients will require surgery and, for some, it can lead to debilitating symptoms of constipation, pain and faecal incontinence. Currently, the Oxford grading system through radiological testing is used for classifying severity of rectal intussusception and prolapse; however this does not give us sufficient information about the anal sphincter muscles. The gold standard investigation of the anal sphincter muscles has been manometry which measures anal canal pressure at rest and during squeeze. However, it has limitations. In previous studies AAR has shown promise in the assessment of faecal incontinence and, that unlike manometry, it has been able to distinguish between different types of incontinence. Thus far, it has not been studied in patients with rectal intussusception and it is hoped that AAR parameters may provide an indication of when rectal intussusception becomes overt rectal prolapse. This can inform the clinician to guide further management of a group of patients with a condition that can have significant impact on quality of life.

NCT ID: NCT02772874 Completed - Fecal Incontinence Clinical Trials

Fecal Incontinence Subtypes in Women With Pelvic Floor Disorders

FIST
Start date: June 2014
Phase: N/A
Study type: Observational

Fecal incontinence (FI) is clinically subtyped as urge FI and passive FI based on symptoms, however the pathophysiologic significance of this subtyping is not known. FI is commonly encountered in women with pelvic floor disorders. This study aims to compare characteristics of clinical severity, quality of life, anatomy, and physiology of urge FI versus passive FI. Urogynecology patients greater than age 18 with FI at least monthly over the last 3 months will be recruited for participation. Participants will be divided into urge FI subtype and passive FI subtype. Participants will complete validated questionnaires on clinical severity and quality of life, both as related to FI and general heath. Participants will undergo pelvic examination, endoanal ultrasound and anorectal manometry for evaluation of anatomic and physiologic pathology. Results between both groups will be compared. The investigators hypothesize that clinical, anatomic, and physiologic characteristics differ between urge-predominant fecal incontinence and passive-predominant fecal incontinence in women with pelvic floor disorders.

NCT ID: NCT02758561 Completed - Clinical trials for Pelvic Floor Disorders

Motivational Interviewing in Women`s Pelvic Wellness Education

Start date: May 2016
Phase: N/A
Study type: Interventional

This pilot study will assess the feasibility and acceptability of an educational workshop on pelvic floor disorders and its potential impact on decisional conflict.

NCT ID: NCT02661867 Completed - Clinical trials for Pelvic Floor Disorders

Pelvic Floor Function Evaluation of Singleton Primiparae After Vaginal Delivery and Cesarean Section

Start date: January 2002
Phase: N/A
Study type: Observational

Objective of this longitudinal observational cohort study was to analyze incidence of pelvic floor dysfunction (PFD) symptoms, including pelvic organ prolapse (POP), urinary incontinence (UI), and fecal incontinence (FI), seven to twelve years after delivery, in two groups of singleton primiparae after vaginal delivery (VD) and cesarean section (CS).

NCT ID: NCT02643108 Active, not recruiting - Fecal Incontinence Clinical Trials

Lateral Episiotomy or Not in Vacuum Assisted Delivery in Non-parous Women

EVA
Start date: June 30, 2017
Phase: N/A
Study type: Interventional

Nulliparous women with a live singleton pregnancy in cephalic presentation past 34 gestational weeks will be randomized to lateral episiotomy or no episiotomy when operative vaginal delivery by vacuum extraction is indicated. Primary outcome is clinically diagnosed obstetric anal sphincter injury (OASIS) of any degree.

NCT ID: NCT02431897 Completed - Clinical trials for Pelvic Organ Prolapse

Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen

IMPROVE
Start date: December 2016
Phase: Phase 4
Study type: Interventional

This study randomizes postmenopausal women with symptomatic pelvic organ prolapse planning native tissue transvaginal surgical repair to 6-8 weeks of preoperative and 1-year continued postoperative vaginal estrogen cream compared to placebo cream. This clinical trial and basic science investigation are designed to understand the mechanisms by which local estrogen treatment affects connective tissues of the pelvic floor and determine whether its use before and after prolapse repair will (i) improve success rates of the surgical intervention and minimize prolapse recurrence and (ii) impact favorably upon symptoms of other pelvic floor disorders.

NCT ID: NCT02391753 Completed - Clinical trials for Pelvic Floor Disorders

Evaluation of Labor Related Pelvic Floor Changes: A 3D Transperineal Ultrasound Study

OTELaPFC
Start date: July 2014
Phase: N/A
Study type: Observational

The aim of the study was the define changes LAM morphology, biometric measurements of the LAM and genital hiatus at immediate evaluation of pelvic floor and at 3 month after delivery was evaluated. We also sought to define the optimal time for evaluation of pelvic floor after childbirth

NCT ID: NCT02334150 Completed - Healthy Clinical Trials

Epidural Analgesia on Electrophysiological Function

Start date: June 2013
Phase: Phase 2/Phase 3
Study type: Interventional

Combined spinal-epidural analgesia (CSEA) is sometimes used for difficult births, but whether it contributes to postpartum pelvic muscle disorder is unclear. This randomized controlled trial examined whether CSEA affects the electrophysiological index of postpartum pelvic floor muscle during labor. The investigators plan to recruit 300 primiparous healthy women.